Clinical Trial Update: Study of Perifosine + Capecitabine for Colon Cancer Patients [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated perifosine in combination with capecitabine for colon cancer. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Perifosine (perifosine)

Snippet

Sponsor: AEterna Zentaris | Conditions: Colon Cancer | Phase 1 | Status: COMPLETED